bioRxiv Science⌕ Search

Biology subjects

Kuchel, G.

Publications and source records attributed to Kuchel, G..

3 recordsLinked to original sources

DIANNE: Segmentation-Free Localization of Histology Differential Attributes

Pathologist-guided distinctions within histology and spatial omic images provide insights into health and disease, with digital pathology leveraging artificial intelligence to automate such assessments. To train computational models, current digital pathology methods rely on upfront manual annotations, which are time-consuming to generate. Pre-annotation is poorly suited to investigating novel spatial behaviors--a major need driven by advances in spatial profiling--for which annotation criteria and data needs will be uncertain. To address these challenges, we present DIANNE, a digital pathology annotation support and discovery approach for rapid training and inference of spatial differential attributes, enabled by train-time Positive Class Mixup Augmentation. DIANNE can compute foundation model-derived segmentation-free localization of differential classifiers across whole slide H&E images within seconds on a workstation, enabling interactive investigation of spatial niches. Predictive models can be re-trained in real-time in response to patch or regional annotation changes, clarifying determinative biological attributes across slides from only a few dozen annotated patches. We demonstrate the effectiveness of DIANNE for tumor detection, artifact identification, and exploration of pancreatic, fetal membranes and kidney tissue structures. DIANNE also provides analogous capabilities for IHC, multiplex immunofluorescence, and registered spatial transcriptomic+H&E images. DIANNE is implemented in a Jupyter toolkit, enabling rapid development of high-resolution classifiers from weakly-supervised training. DIANNE provides a practical system to quantitatively understand known and novel spatial phenotypes.

pathology↗

CMV reshapes lymphoid immunity in aging: a single-cell atlas with predictive modeling

Cytomegalovirus (CMV) is a common herpesvirus that establishes lifelong latency and becomes increasingly prevalent with age. We systematically characterized CMV-associated immune remodeling by analyzing six human cohorts (two newly built) using single-cell RNA sequencing, T cell receptor (TCR) sequencing, and flow cytometry. Beyond the well-known expansion of CD4/CD8 TEMRA, adaptive NK, and {gamma}{delta} T cells, CMV(+) adults exhibited increased frequencies of GZMK CD8 T cells and atypical B cells, alongside a reduction of CD56dim NK cells. Longitudinal profiling of an individual who seroconverted revealed rapid CMV-driven shifts in circulating immune cell frequencies. Single-cell TCR data analyzed using a large database of CMV-associated clones combined with predictive modelling (CMVerify), identified novel CMV-specific clonal expansions reproduced across two independent cohorts. In the CD8 lineage, CMV-specific clones were enriched in GZMK CD8 and CD8 TEMRA cells, while in the CD4 lineage, Th1 cells showed clonal expansion alongside CD4 TEMRA cells. This integrative study revealed how latent CMV alters the cellular and clonal landscape, defining GZMK CD8 and Th1 cells as newly recognized elements of response to CMV in humans.

immunology↗

A Multi-Phenotype System to Discover Therapies for Age-Related Dysregulation of the Immune Response to Viral Infections

Age-related immune dysregulation contributes to increased susceptibility to infection and disease in older adults. We combined high-throughput laboratory automation with machine learning to build a multi-phenotype aging profile that models the dysfunctional immune response to viral infection in older adults. From a single well, our multi-phenotype aging profile can capture changes in cell composition, physical cell-to-cell interaction, organelle structure, cytokines, and other hidden complexities contributing to age-related dysfunction. This system allows for rapid identification of new potential compounds to rejuvenate older adults immune response. We used our technology to screen thousands of compounds for their ability to make old immune cells respond to viral infection like young immune cells. We observed beneficial effects of multiple compounds, of which two of the most promising were disulfiram and triptonide. Our findings indicate that disulfiram could be considered as a treatment for severe coronavirus disease 2019 and other inflammatory infections.

immunology↗